Burak Kardeşler

Burak Kardeşler

Auto-generated profile, based on publicly available information

Burak Kardeşler

Department of Cardiology, Ankara Bilkent City Hospital, Ankara 06800, Türkiye

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2026 in Clinical Research in Cardiology
Verified
Journal Article
Open access
PDF file
KKKamuran Kalkan
Kamuran Kalkan
VTVEYSEL OZAN TANIK
VEYSEL OZAN TANIK
BKBurak Kardeşler
Burak Kardeşler
EKEtga Köprücü
Etga Köprücü
GÇGülnur Çolak
Gülnur Çolak
BÖBülent Özlek
Bülent Özlek
Background: Malignant ventricular arrhythmias (MVA)—sustained ventricular tachycardia or fibrillation—remain a major early complication after ST-segment elevation myocardial infarction (STEMI) despite timely reperfusion. The no-reflow phenomenon is a key substrate for arrhythmogenesis. The no-reflow prediction in acute coronary syndrome (NORPACS) score, originally developed to predict no-reflow, may also help identify patients at high arrhythmic risk. Methods: We retrospectively analyzed 1050 consecutive STEMI patients undergoing successful primary percutaneous coronary intervention (PCI) between January 2020 and December 2024. The primary endpoint was inhospital MVA. Univariable and multivariable logistic regression models were constructed incorporating clinical, laboratory, and angiographic variables. The incremental predictive value of the NORPACS score was assessed using receiver operating characteristic analysis, net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Kaplan–Meier and restricted cubic spline analyses evaluated temporal risk patterns. Results: MVA occurred in 79 patients (7.5%), all within the first 8-h post-PCI. Patients with MVA more often had diabetes, anterior infarcts, lower LVEF, higher inflammatory markers, and no-reflow. The NORPACS score was significantly higher in the MVA group (7.1 ± 1.3 vs. 6.2 ± 1.7, p < 0.001) and independently predicted events across all multivariable models (adjusted OR range: 1.20–1.44, all p < 0.05). Adding NORPACS to clinical–laboratory models improved discrimination (ΔAUC up to 0.07) and yielded significant IDI (0.022–0.024) and NRI (0.10–0.14). Kaplan–Meier curves confirmed earlier arrhythmia onset with higher scores. Conclusions: The NORPACS score is an independent and incremental predictor of early MVA in STEMI patients undergoing PCI. Its integration into clinical–laboratory risk models enhances risk stratification and may guide intensified monitoring in high-risk patients. Prospective multicenter validation is warranted. Graphical This study evaluated the prognostic utility of the NORPACS score for predicting malignant ventricular arrhythmias (VT/VF) in 1050 patients with STEMI undergoing successful primary PCI. The NORPACS score, incorporating angiographic and clinical parameters such as TIMI flow, vessel diameter, stent length, shock status, and ischemia time, was independently associated with inhospital VT/VF risk. Higher NORPACS scores were linked to a stepwise increase in arrhythmic events, as demonstrated by ROC, spline, and Kaplan–Meier analyses. The score remained a significant predictor across all multivariable models (adjusted OR range: 1.20–1.44, all p < 0.05).

5 September 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
KEKemal Eşref Erdoğan
Kemal Eşref Erdoğan
EUEmrah Uguz
Emrah Uguz
MEMehmet Akif Erdöl
Mehmet Akif Erdöl
MSMuhammet Fethi Sağlam
Muhammet Fethi Sağlam
Murat YUCELMurat YUCEL
Murat YUCEL
KKKamuran Kalkan
Kamuran Kalkan
Background/Objectives: Transaxillary access (TAx) is an established alternative to transfemoral access (TF) for transcatheter aortic valve implantation (TAVI) in patients with unfavorable iliofemoral anatomy. While TAx-TAVI has been increasingly adopted at experienced centers, propensity score-matched comparative data with VARC-3 endpoint definitions are scarce, and most existing series originate from Western European cohorts. We aimed to address this gap by reporting outcomes from a propensity-matched TAx versus TF cohort using VARC-3 endpoints, contributing contemporary data from a high-volume Turkish center with established alternative access expertise. Methods: Among 2389 consecutive TAVI procedures screened between January 2016 and December 2024, 291 patients with complete data were included. After stratification by access route (TAx n = 51; TF n = 240) and exclusion of one TAx patient with missing covariates, 1:2 greedy nearest-neighbor propensity score matching was performed using nine covariates. The final cohort comprised 150 patients (50 TAx, 100 TF). All outcomes were defined per VARC-3 criteria. Results: All nine covariates achieved standardized mean differences <0.1 after matching. Technical success was comparable (TAx 94.0% vs. TF 96.0%; p = 0.686). The VARC-3 early safety event rate did not differ significantly (16.0% vs. 15.0%; p = 1.000); no equivalence can be inferred given the small event counts and wide confidence intervals. Any bleeding (VARC-3) was significantly lower in the TAx group (8.0% vs. 22.0%; OR 0.31, 95% CI 0.10–0.95; p = 0.039), confirmed by conditional logistic regression for the matched structure (OR 0.32 [0.10–0.97]; p = 0.043); this should be considered an exploratory finding. Thirty-day all-cause mortality (encompassing in-hospital deaths) (6.0% vs. 10.0%; p = 0.545), 1-year mortality (12.0% vs. 16.0%; p = 0.628), and Kaplan–Meier 1-year survival (88.0% vs. 84.0%; log-rank p = 0.510) did not differ significantly. ICU stay (median 2 [1–2] vs. 2 [1–3] days; p = 0.020) and hospital stay (median 5 [4–6] vs. 5 [4–6] days; p = 0.005) yielded statistically significant p-values; however, medians were identical in both comparisons, and significance was driven by outlier-prolonged admissions in the TF group rather than a meaningful difference in typical recovery duration. Conclusions: TAx-TAVI demonstrated comparable mortality, safety, and hemodynamic outcomes to TF-TAVI, with a significantly lower rate of bleeding complications. Axillary access represents a safe and effective alternative route in patients unsuitable for transfemoral TAVI.

29 April 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KEKemal Eşref Erdoğan
Kemal Eşref Erdoğan
BKBurak Kardeşler
Burak Kardeşler
MSMuhammet Fethi Sağlam
Muhammet Fethi Sağlam
EUEmrah Uguz
Emrah Uguz
Murat YUCELMurat YUCEL
Murat YUCEL
EŞErol Şener
Erol Şener
Background/Objectives: Every hour of delay in treating acute aortic dissection (AAD) increases mortality by 1–2%, underscoring the critical need for rapid identification of high-risk patients. Despite advances in surgical management, in-hospital mortality remains substantial, and early, reliable risk stratification tools are urgently needed. We targeted to assess the relationship between the De Ritis ratio (DRr) and in-hospital mortality in patients experiencing surgery for AAD. Methods: In this single-center retrospective study, 182 patients who underwent surgery for AAD between 2020 and 2025 were included. Demographic, clinical, laboratory, and echocardiographic data were analyzed. Receiver operating characteristic analysis was used to estimate the DRr’s discriminatory ability, and univariable and multivariable logistic regression analyses were utilized to find predictors of in-hospital mortality. Results: In-hospital mortality occurred in 59 patients (32.4%). When comparing survivors to non-survivors, the DRr was noticeably greater. Along with age, lactate level, and ejection fraction, the DRr continued to be an independent predictor of in-hospital mortality in multivariable analysis. Receiver operating characteristic analysis showed moderate discriminatory performance of the DRr, with an area under the curve of 0.701 and an optimal cut-off value of 1.308. Conclusions: The DRr is a practical and accessible biomarker related to in-hospital mortality in surgically treated AAD and may provide incremental prognostic value when used alongside established clinical and laboratory parameters.

13 October 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KEKemal Eşref Erdoğan
Kemal Eşref Erdoğan
MSMuhammet Fethi Sağlam
Muhammet Fethi Sağlam
SBSerdal Baştuğ
Serdal Baştuğ
BKBurak Kardeşler
Burak Kardeşler
EUEmrah Uguz
Emrah Uguz
MAMurat Akçay
Murat Akçay
Background/Objectives: Real-world data comparing treatment strategies and in-hospital outcomes across no index revascularization, percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG) in NSTEMI patients remain limited. Methods: In this single-center retrospective cohort study, 1906 NSTEMI patients undergoing coronary angiography were categorized into no index revascularization (n = 946), PCI (n = 709), or CABG (n = 251) groups. The primary endpoint was in-hospital major adverse cardiovascular events (MACE), defined as all-cause mortality, cardiac arrest requiring cardiopulmonary resuscitation, sustained ventricular tachycardia/ventricular fibrillation, dialysis-requiring acute kidney injury, or stroke. Missing data were handled using multiple imputation with chained equations (MICE), and propensity score-based inverse probability of treatment weighting (IPTW) was used as a sensitivity analysis. Results: In-hospital MACE was higher in the no index revascularization group than in the PCI and CABG groups (9.8% vs. 3.5% vs. 4.8%; p < 0.001). Patients managed with no index revascularization were older and had a greater comorbidity burden, lower left ventricular ejection fraction, and more frequent Killip class ≥ 2. In the primary multivariable model, chronic kidney disease, Killip class ≥ 2, lower LVEF, CRP, and male sex were associated with in-hospital MACE, whereas neither PCI nor CABG strategy was independently associated with MACE. IPTW sensitivity analyses yielded similar directions of association; however, the PCI estimate crossed the conventional significance threshold after 1st–99th percentile weight truncation. Conclusions: Patients managed with no index revascularization had a higher baseline risk profile and higher unadjusted in-hospital MACE and mortality. The observed between-group differences should be interpreted as associations rather than causal effects of treatment strategy because of substantial confounding by indication.

14 October 2025 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
BKBurak Kardeşler
Burak Kardeşler
SBSerdal Baştuğ
Serdal Baştuğ
KKKamuran Kalkan
Kamuran Kalkan
MEMehmet Erdoğan
Mehmet Erdoğan
FKFurkan Külekci̇
Furkan Külekci̇
TDTahi̇r Durmaz
Tahi̇r Durmaz
Background/aim: In-stent restenosis (ISR) remains a significant clinical challenge in patients undergoing percutaneous coronary interventions. We investigated the association between Prognostic Nutritional Index (PNI) and ISR in patients with chronic coronary syndrome. Materials and methods: A total of 1007 patients who underwent coronary angiography for a provisional diagnosis of chronic coronary syndrome between March 1, 2019, and July 1, 2022, were included in the study. They were divided into two groups: ISR (n = 395) and non-ISR (n = 612). PNI was calculated using patients’ laboratory values before coronary angiography with the following formula: PNI = (10 × albumin (g/dL)) + (0.005 × total lymphocyte count (per mm3)). Results: The mean age of the patients was 62 ± 10 years, and 75% of the patients (n = 760) were male. The calculated PNI was 42.83 ± 3.53 in the non-ISR group and 44.43 ± 3.74 in the ISR group (p < 0.001). When the validity of the PNI for ISR was statistically examined, the AUC was calculated as 0.64 (0.61–0.68). The cutoff value for PNI was determined to be 44, which predicted stent ISR with a sensitivity of 61% and a specificity of 61%. Conclusion: Contrary to the findings in the literature, our study revealed a higher Prognostic Nutritional Index (PNI) value in the stent ISR group than in the non-ISR group. The PNI reflects the current nutritional status, whereas stent ISR is an outcome of a chronic clinical condition.